• Home
  • Search Results

Research Studies

UNC-Chapel Hill Lineberger Comprehensive Cancer Center

Cancer - Leukemia
36 studies match your search
Open

Myelodysplastic Syndrome or Acute Myeloid Leukemia study

Do you have AML or MDS and are not eligible to receive intensive chemotherapy? Are you looking for another treatment option? In this study, we want to see if the study drug, SL-172154, works better alone or in combination azacitidine or with azacitidine and venetoclax.

Age & Gender
  • 18 years ~ 75 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Polycythemia Vera Study

Do you havepolycythemia vera (PV)? If you need to start therapy or your currently therapy is not controlling your PV, you may be able to take part in this research study to find out if a new drug can help normalize your blood count.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Coming Soon

An Acute Leukemia Study

The purpose of this study is to find out if treatment with the study drug, Bexmarilimab, along with standard of care can help with your type of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Study for Blood Cancer

Have you been diagnosed with Leukemia? You may be able to take part in a research study to find out if a new study drug can help put your blood cancer into remission.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)

High Risk Myelofibrosis Study

This is a research study for people diagnosed with High Risk Myelofibrosis. The purpose of this study is to see if the study drug BMS-986158 works better alone or in combination with ruxolitinib or fedratinib.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Chronic Myelogenous Leukemia Study

Have you been diagnosed with Leukemia and looking for another option? Do you have Chronic Myelogenous Leukemia? In this study, we want to learn more about how effective the study drug (asciminib) works for patients with CML-CP who have had one prior therapy.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Myelofibrosis Treatment Study

Have you been diagnosed with Leukemia and looking for another treatment option? Do you have Myelofibrosis (MF), myelodysplastic syndrome (MDS) and /or myelodysplastic/myeloproliferative overlap syndrome (MDS/MPN)? You may be able to take part in this study to find out the safety and effectiveness of a study drug.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Understanding Outcome Differences in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL)

If you or your child has been diagnosed with acute lymphoblastic leukemia (ALL), you or they might be able to take part in a research study. This study aims to understand why there are differences in outcomes in adolescents and young adults treated for ALL.

Age & Gender
  • 15 years ~ 39 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers, Leukemia)
  • Child and Teen Health
Open

Relapsed or Refractory Leukemia Study

Do you have Leukemia and recent test results show that the signs and symptoms of your cancer have returned? Are you looking for another treatment option? In this study, we want to see if a study medication can treat your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Leukemia)

Chronic Lymphocytic Leukemia Study

The purpose of this study is to collect more information about how effective a combination of medications are in treating CLL in people who have not received previous treatment for their cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Leukemia)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research